Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML
In: Blood advances, Jg. 8 (2024), Heft 2, S. 343-352
Online
academicJournal
Zugriff:
Titel: |
Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML
|
---|---|
Autor/in / Beteiligte Person: | Jimenez-Chillon, C ; Othman, J ; Taussig, D ; Jimenez-Vicente, C ; Martinez-Roca, A ; Tiong, IS ; Jain, M ; Aries, J ; Cakmak, S ; Knapper, S ; Kristensen, DT ; Murthy, V ; Galani, JZ ; Kallmeyer, C ; Ngu, L ; Veale, D ; Bolam, S ; Orfali, N ; Parker, A ; Manson, C ; Parker, J ; Erblich, T ; Richardson, D ; Mokretar, K ; Potter, N ; Overgaard, UM ; Roug, AS ; Wei, AH ; Esteve, J ; Jadersten, M ; Russell, N ; Dillon, R |
Link: | |
Zeitschrift: | Blood advances, Jg. 8 (2024), Heft 2, S. 343-352 |
Veröffentlichung: | 2024 |
Medientyp: | academicJournal |
ISSN: | 2473-9537 (print) |
DOI: | 10.1182/bloodadvances.2023011106 |
Schlagwort: |
|
Sonstiges: |
|